8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Hale Hana
Hāʻawi ka mea hana i ka Linagliptin a me nā mea pili e pili ana:
Linagliptin CAS 668270-12-0
Linagliptin Mākua Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Inoa Kimia | 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine |
Nā huaʻōlelo like | 8-Bromo-7-(2-butyn-1-yl) -3,7-dihydro-3-methyl-1H-purine-2,6-dione;ʻO Linagliptin Intermediate C |
Helu CAS | 666816-98-4 |
Helu CAT | RF-PI497 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C10H9BrN4O2 |
Kaumaha Molecular | 297.11 |
Lae hehee | 285 ℃ |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a hiki i ka pauda keʻokeʻo |
Wai (KF) | ≤0.50% |
Koena ma ka Ignition | ≤0.50% |
Maʻemaʻe/Ana Hana Hana | ≥99.0% (HPLC) |
Max Hoʻokahi haumia | ≤0.50% |
Nā mea hoʻoheheʻe koena | |
Ethanol | ≤5000ppm |
DMF | ≤3000ppm |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Waena no Linagliptin (CAS: 668270-12-0) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.
ʻO 8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine (CAS: 666816-98-4) he mea waena no Linagliptin (CAS: 668270-12-0).ʻO Linagliptin kahi mea hoʻokae waha, koho nui loa o dipeptidyl peptidase-4 a ʻo ia ka mea mua o kāna papa e hoʻopau nui ʻia ma ke ala nonrenal.Hōʻike ʻia ʻo Linagliptin i hoʻokahi manawa i kēlā me kēia lā no ka mālama ʻana i nā pākeke me ka maʻi diabetes type 2.Ua ʻae ʻia ʻo Linagliptin e ka US FDA i Mei 2011 no ka mālama ʻana i ka maʻi maʻi type 2 me ka ʻai a me ka hoʻoikaika kino.